Joseph R. Testa

40.3k citations

347 papers · 24.5k indexed · 9 hit papers · h-index 83

Impact in

Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Molecular Biology top 0.1%
- PI3K/AKT/mTOR signaling in cancer

Papers in

Cancer Research 56
- Cancer Genomics and Diagnostics 29
Hematology 40
- Acute Myeloid Leukemia Research 34

Co-authors: Deborah A. Altomare Alfonso Bellacosa Michele Carbone Philip N. Tsichlis Gonosuke Sonoda Mitchell Cheung Andrew K. Godwin Yasuhiro Mitsuuchi
Journals: Genes Chromosomes and Cancer (18 papers)Oncogene (17 papers)Cancer Research (16 papers)Proceedings of the National Academy of Sciences (16 papers)Genomics (14 papers)
Partner nations: United States Japan Canada

In The Last Decade

Joseph R. Testa

343 papers receiving 24.0k citations

Hit Papers

9 papers align trajectories log scale

BAP1 and cancer 2013 · 462 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Nature reviews. Cancer
2011 Nature Genetics
2005 Oncogene
2005 Advances in cancer research
2001 Proceedings of the National Academy of Sciences
1996 Proceedings of the National Academy of Sciences
1995 International Journal of Cancer
1992 Proceedings of the National Academy of Sciences
1991 Science

Peers

Countries citing papers authored by Joseph R. Testa

Since Specialization

Citations

This map shows the geographic impact of Joseph R. Testa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph R. Testa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph R. Testa more than expected).

Fields of papers citing papers by Joseph R. Testa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph R. Testa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph R. Testa. The network helps show where Joseph R. Testa may publish in the future.

Co-authors

The 25 scholars most cited alongside Joseph R. Testa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joseph R. Testa Line = papers co-authored together Joseph R. Testa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments Cancer Research Communications ·Xiaojun Ma, David Lembersky, Elena S. Kim, Michael J. Becich, Joseph R. Testa, Tullia C. Bruno, Hatice U. Osmanbeyoglu	2024	4
2	Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review Leukemia Research Reports ·Yavuz Şahin, Jianming Pei, Don A. Baldwin, Nashwa Mansoor, Lori Koslosky, Peter Abdelmessieh, Y. Lynn Wang, Reza Nejati, Joseph R. Testa	2024	0
3	The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells Science Signaling ·Alison Kurimchak, Carlos Herrera-Montávez, Sara Montserrat‐Sangrà, Daniela Araiza‐Olivera, Jianping Hu, Ryan Neumann-Domer, Mathew Kuruvilla, Alfonso Bellacosa, Joseph R. Testa, Jian Jin, James S. Duncan	2022	64
4	Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase Molecular Cancer Research ·Hongzhuang Peng, Joel Cassel, Daniel S. McCracken, Jeremy W. Prokop, Eleonora Sementino, Mitchell Cheung, Paul R. Collop, Alexander Polo, Surbhi Joshi, Jacob P. Mandell, Kasirajan Ayyanathan, David A. Hinds, S. Bruce Malkowicz, J. William Harbour, A. Bowcock, Joseph M. Salvino, Eileen J. Kennedy, Joseph R. Testa, Frank J. Rauscher	2021	4
5	Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis Molecular Cancer Therapeutics ·Joy Gary, John K. Simmons, Jinfei Xu, Shuling Zhang, Tyler J. Peat, Nicholas Watson, Benjamin J. Gamache, Ke Zhang, Alexander L. Kovalchuk, Aleksandra M. Michalowski, Jin‐Qiu Chen, Tuddow Thaiwong, Matti Kiupel, Snehal Gaikwad, Maudeline Etienne, Richard J. Simpson, Wendy Dubois, Joseph R. Testa, Beverly A. Mock	2020	8
6	Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma Clinical Cancer Research ·Yinfei Tan, Eleonora Sementino, Mitchell Cheung, Suraj Peri, Craig W. Menges, Anna-Mariya Kukuyan, Ting Zhang, Vladimir Khazak, Lauren A. Fox, Eric A. Ross, Suresh Y. Ramanathan, Suresh C. Jhanwar, Raja M. Flores, Siddharth Balachandran, Joseph R. Testa	2020	38
7	Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models Cancer Research ·Anna-Mariya Kukuyan, Eleonora Sementino, Yuwaraj Kadariya, Craig W. Menges, Mitchell Cheung, Yinfei Tan, Kathy Q. Cai, Michael Slifker, Suraj Peri, Andres J. Klein–Szanto, Frank J. Rauscher, Joseph R. Testa	2019	41
8	Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains Cancer Research ·Hongzhuang Peng, Jeremy W. Prokop, Jayashree Karar, Kyewon Park, Li Cao, J. William Harbour, A. Bowcock, S. Bruce Malkowicz, Mitchell Cheung, Joseph R. Testa, Frank J. Rauscher	2017	20
9	Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer Cancer Research ·Jill Ohar, Mitchell Cheung, Jacqueline Talarchek, Suzanne E. Howard, Timothy D. Howard, Mary Hesdorffer, Hongzhuang Peng, Frank J. Rauscher, Joseph R. Testa	2016	64
10	Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma Cancer Prevention Research ·Yuwaraj Kadariya, Craig W. Menges, Jacqueline Talarchek, Kathy Q. Cai, Andres J. Klein–Szanto, Ralph A. Pietrofesa, Melpo Christofidou‐Solomidou, Mitchell Cheung, Brooke T. Mossman, Arti Shukla, Joseph R. Testa	2016	59
11	Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma Cancer Research ·Jinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, Jianming Pei, Jacqueline Talarchek, Eleonora Sementino, Yinfei Tan, Craig W. Menges, Kathy Q. Cai, Samuel Litwin, Hongzhuang Peng, Jayashree Karar, Frank J. Rauscher, Joseph R. Testa	2014	107
12	Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary Molecular Cancer Therapeutics ·Takeshi Hisamatsu, Seiji Mabuchi, Yuri Matsumoto, Mahiru Kawano, Tomoyuki Sasano, Ryoko Takahashi, Kenjiro Sawada, Kimihiko Ito, Hirohisa Kurachi, Russell J. Schilder, Joseph R. Testa, Tadashi Kimura	2013	37
13	Tumor Suppressor Alterations Cooperate to Drive Aggressive Mesotheliomas with Enriched Cancer Stem Cells via a p53–miR-34a–c-Met Axis Cancer Research ·Craig W. Menges, Yuwaraj Kadariya, Deborah A. Altomare, Jacqueline Talarchek, Erin Neumann-Domer, Yue Wu, Guang‐Hui Xiao, Irina M. Shapiro, Vihren N. Kolev, Jonathan A. Pachter, Andres J. Klein–Szanto, Joseph R. Testa	2013	47
14	NF-κB Inhibition by Bortezomib Permits IFN-γ–Activated RIP1 Kinase–Dependent Necrosis in Renal Cell Carcinoma Molecular Cancer Therapeutics ·Roshan J. Thapa, Peirong Chen, Mitchell Cheung, Shoko Nogusa, Jianming Pei, Suraj Peri, Joseph R. Testa, Siddharth Balachandran	2013	19
15	Group I p21-Activated Kinases (PAKs) Promote Tumor Cell Proliferation and Survival through the AKT1 and Raf–MAPK Pathways Molecular Cancer Research ·Craig W. Menges, Eleonora Sementino, Jacqueline Talarchek, Jinfei Xu, Jonathan Chernoff, Jeffrey R. Peterson, Joseph R. Testa	2012	40
16	Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling Cancer Research ·Yinfei Tan, Mitchell Cheung, Jianming Pei, Craig W. Menges, Andrew K. Godwin, Joseph R. Testa	2010	51
17	GSK690693 Delays Tumor Onset and Progression in Genetically Defined Mouse Models Expressing Activated Akt Clinical Cancer Research ·Deborah A. Altomare, Lili Zhang, Jing Deng, Antonio Di Cristofano, Andres J. Klein–Szanto, Rakesh Kumar, Joseph R. Testa	2010	43
18	A Novel Recurrent Chromosomal Inversion Implicates the Homeobox Gene Dlx5 in T-Cell Lymphomas from Lck-Akt2 Transgenic Mice Cancer Research ·Yinfei Tan, Roman A. Timakhov, Mamta Rao, Deborah A. Altomare, Jinfei Xu, Zemin Liu, Qingshen Gao, Suresh C. Jhanwar, Antonio Di Cristofano, David L. Wiest, Janice E. Knepper, Joseph R. Testa	2008	29
19	A Novel Mechanism of Late Gene Silencing Drives SV40 Transformation of Human Mesothelial Cells Cancer Research ·Michele Carbone, Antonio Pannuti, Lei Zhang, Joseph R. Testa, Maurizio Bocchetta	2008	24
20	RAD001 (Everolimus) Delays Tumor Onset and Progression in a Transgenic Mouse Model of Ovarian Cancer Cancer Research ·Seiji Mabuchi, Deborah A. Altomare, Denise C. Connolly, Andres J. Klein–Szanto, Samuel Litwin, Matthew K. Hoelzle, Harvey H. Hensley, Thomas C. Hamilton, Joseph R. Testa	2007	156

About Joseph R. Testa

Joseph R. Testa is a scholar working on Cancer Research, Hematology, Pulmonary and Respiratory Medicine, Oncology and Biotechnology, having authored 347 papers that have together received 24.5k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (68 papers), PI3K/AKT/mTOR signaling in cancer (38 papers), Acute Myeloid Leukemia Research (34 papers), Cancer Genomics and Diagnostics (29 papers), Cancer-related Molecular Pathways (28 papers), Genomic variations and chromosomal abnormalities (28 papers), Renal and related cancers (26 papers) and Medical Imaging and Pathology Studies (24 papers). The work is most often cited by research in Cancer Research (3.9k citations), Molecular Biology (14.1k citations), Oncology (5.4k citations), Pulmonary and Respiratory Medicine (5.9k citations) and Pathology and Forensic Medicine (2.4k citations). Joseph R. Testa has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Deborah A. Altomare, Alfonso Bellacosa, Michele Carbone, Philip N. Tsichlis, Gonosuke Sonoda, Mitchell Cheung, Andrew K. Godwin, Yasuhiro Mitsuuchi, Harvey I. Pass and Andres J. Klein–Szanto. Their work appears in journals such as Genes Chromosomes and Cancer, Oncogene, Cancer Research, Proceedings of the National Academy of Sciences and Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact